Skip to main content
CDC Website

Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI).

Funding Organization:
US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Support Types:
Discretionary Grants
Locations:
International
National
Award Amount:
$ 275,000
Fund Number:
364390
Fund ID:
PAR-20-054
Application Due Date:
Subjects:
HIV
STD/STI Prevention
Audiences:
At Risk Persons
Persons with STD/STI
LGBTQ
Last Updated:
Application Contact
Ann
Devine
Grants Management Specialist
240.669.2988
adevine@niaid.nih.gov
Technical Contact
James
Cummins
Scientific/Research Contact NIAID
cumminsje@niaid.nih.gov